Assessing the Effect of the 'Wavy' Application, on Stress and Burden of Disease in Women With INOCA

NCT06171893 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 117

Last updated 2024-01-19

No results posted yet for this study

Summary

For women that experience angina symptoms with underlying vascular spasm as the cause, stress has an aggravating role. Coping with stress is therefore included as an important pillar in dealing with this chronic disease, see the European Association of Percutaneous Cardiovascular Interventions (EACPI) consensus document on INOCA. In practice, stress management focuses on informing and identifying the role stress plays in their lives. A potential stress management tool: "Wavy" aims to help users manage stress more consciously through biofeedback. This research focuses on the effectiveness of stress management applications. The hypothesis is that the app will help to avoid the trigger stress as much as possible and thus reduce the burden of disease.

Conditions

  • Stress
  • Ischemia
  • Vasospasm, Coronary
  • Vasomotor; Spasm
  • Angina, Stable
  • Prinzmetal Angina

Interventions

BEHAVIORAL

Wavy stress application

The intervention consists of the application named Wavy. Wavy uses artificial intelligence and the user's feedback to detect stress increasingly more efficient over time. This provides not only real-time feedback on an individual's stress level but also helps the patient to calm down using music guided relaxation. It does so with a music filter, allowing the participant to listen to music where the stress level determines the quality of the music. Thus, relaxing is rewarded by improving the experience. In this process, implicit learning is used to establish a habit of getting better at recognising increased stress levels and getting familiar with reducing stress levels more and more effectively.

Sponsors & Collaborators

  • VieCuri Medical Centre

    collaborator OTHER
  • The Elisabeth-TweeSteden Hospital

    collaborator OTHER
  • Maastricht University Medical Center

    collaborator OTHER
  • Maasstad Hospital

    collaborator OTHER
  • Catharina Ziekenhuis Eindhoven

    collaborator OTHER
  • ZonMw: The Netherlands Organisation for Health Research and Development

    collaborator OTHER
  • Health Holland

    collaborator OTHER
  • Netherlands Organisation for Scientific Research

    collaborator OTHER_GOV
  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Suzette Elias-Smale, dr. · Radboud University Medical Center

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2022-12-23
Completion
2022-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06171893 on ClinicalTrials.gov